Developer docs
API playgroundTry for free, no card

Search company profiles

Moichor

Full company profile

uuid0002f5t

Namestring
Moichor
Legal namestring
Moichor Inc.
Websiteurl
moichor.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Moichor Inc. is a San Francisco-based veterinary diagnostics company founded in 2019 that builds AI-powered point-of-care and reference lab tools for animal health. Its core product, Pathview, is described as the first image-based complete blood count (CBC) device in the veterinary market; it uses computer vision algorithms trained on more than 2 million pathology objects spanning over 350 species to deliver preliminary hematology and cytology results in as little as 15 minutes, with board-certified pathologist review available on a STAT basis within two hours. The company also operates a Reference Lab service that provides remote pathology interpretation to clinics without in-house Pathview systems.

The business operates a hybrid revenue model combining hardware sales of Pathview systems, recurring consumables revenue tied to each device placement, and professional pathology services. Pricing is not publicly disclosed, though the company claims average cost savings of 35%+ versus traditional reference lab testing. Moichor serves two primary customer segments: companion animal practices (dogs and cats) and exotic animal hospitals (birds, reptiles, ferrets, and other non-traditional pets), with secondary exposure to point-of-care emergency settings. Named customers include specialty providers such as MedVet, GCVS Healthcare, and NorthStar VETS, alongside mid-market general practice and exotic clinics.

Moichor distributes directly through its own sales motion and demo-request funnel, and — as of a February 2026 commercial agreement — through a channel partnership with Zomedica Corp. to sell co-branded TRUVIEW digital microscopy systems integrated with Moichor's AI engine and pathology services across the United States. The company has raised approximately $4 million in disclosed seed funding (led by Neotribe Ventures with Y Combinator participation in April 2021) and operates with 11–50 employees. It is privately held with no parent company and no public listing.

Short descriptiontext

Moichor is a San Francisco-based veterinary diagnostics company that sells Pathview, an AI-powered point-of-care hematology and cytology system trained on 2M+ pathology objects across 350+ species, serving companion animal practices, exotic animal hospitals, and emergency veterinary settings with a hybrid hardware, consumables, and reference lab model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary diagnostics, AI pathology analysis, hematology cytology systems, point-of-care diagnostics, veterinary reference lab
Industry4 codes
PRIMARYHLAMADAI
Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAMADAA
Reference Laboratory Testing (Clinical Pathology & Chemistry)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAMAMAG
Veterinary Lab/Imaging Integration & LIS/PACS Connectivity
SECONDARYAFAEANAF
Veterinary Diagnostic Laboratories & Pathology
NAICS code3 codes
  • Veterinary Services541940
  • Medical and Diagnostic Laboratories6215
  • Medical Laboratories621511
SIC code2 codes
  • Services-Medical Laboratories8071
  • Laboratory Analytical Instruments3826
Product category
Veterinary Diagnostics Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pathview System Sales
TypeHardware Sales
Description

Sale of AI-powered Pathview image-based CBC and cytology devices to veterinary clinics. First commercially available devices began shipping September 2022.

stocktitan.net
2Recurring Consumables Revenue
TypeSubscription Recurring
Description

Each TRUVIEW system placement generates recurring consumables revenue as system placements grow across customer network. Consumables include testing supplies and reagents needed for diagnostic tests.

biospace.com
3Pathology Services
TypeProfessional Services
Description

Board-certified pathology services integrated with AI engine, providing expert interpretation of diagnostic results for veterinary practices.

moichor.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Pathview
Description

AI-assisted hematology and cytology system for veterinary clinics, providing pathologist-level results assisted by AI with results in as little as 15 minutes.

moichor.com
+1 more record
Core offering1 text field

Moichor sells an AI-assisted hematology and cytology point-of-care diagnostic system (Pathview) for veterinary clinics, using computer vision trained on over 2 million pathology objects spanning 350+ species to deliver preliminary diagnostic results in 15 minutes. The company also operates a veterinary Reference Lab service providing board-certified pathology expertise for clinics without in-house Pathview systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 35%+ average cost savings for veterinary clinics
+3 more records
Product overview1 text field

Moichor offers AI-powered veterinary diagnostic products centered on its Pathview platform — an AI-assisted hematology and cytology system for point-of-care clinics — complemented by a Reference Lab service that provides remote pathology expertise. Both products leverage computer vision trained on millions of pathology samples to deliver rapid diagnostic results within 15 minutes, supporting CBC and cytology evaluation across more than 350 species including companion animals, birds, reptiles, and exotic animals.

Product and service2 records
1Pathview
CategoryVeterinary Diagnostics Software
Description

AI-assisted hematology and cytology system designed for point-of-care veterinary clinics. Provides pathologist-level results in as little as 15 minutes, performing CBC and cytology evaluation for any species including companion animals, birds, reptiles, and exotic animals.

2Reference Lab
CategoryVeterinary Diagnostics Services
Description

Veterinary pathology services providing access to board-certified pathology expertise for clinics that do not have in-house Pathview systems, offering comprehensive diagnostic support for veterinary practices nationwide.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-25
Description

Commercial distribution agreement under which Zomedica supplies its TRUVIEW digital microscopy systems and associated testing supplies for Moichor's sale to point-of-care veterinary customers nationwide. The co-branded systems integrate Moichor's proprietary AI engine and board-certified pathology services, expanding the TRUVIEW platform's reach into companion animal practices and exotic animal hospitals. Each system placement is expected to generate recurring consumables revenue.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Moichor

Veterinary Diagnostics Softwaremoichor.com

Moichor is a San Francisco-based veterinary diagnostics company that sells Pathview, an AI-powered point-of-care hematology and cytology system trained on 2M+ pathology objects across 350+ species, serving companion animal practices, exotic animal hospitals, and emergency veterinary settings with a hybrid hardware, consumables, and reference lab model.

What Moichor does

Moichor Inc. is a San Francisco-based veterinary diagnostics company founded in 2019 that builds AI-powered point-of-care and reference lab tools for animal health. Its core product, Pathview, is described as the first image-based complete blood count (CBC) device in the veterinary market; it uses computer vision algorithms trained on more than 2 million pathology objects spanning over 350 species to deliver preliminary hematology and cytology results in as little as 15 minutes, with board-certified pathologist review available on a STAT basis within two hours. The company also operates a Reference Lab service that provides remote pathology interpretation to clinics without in-house Pathview systems.

The business operates a hybrid revenue model combining hardware sales of Pathview systems, recurring consumables revenue tied to each device placement, and professional pathology services. Pricing is not publicly disclosed, though the company claims average cost savings of 35%+ versus traditional reference lab testing. Moichor serves two primary customer segments: companion animal practices (dogs and cats) and exotic animal hospitals (birds, reptiles, ferrets, and other non-traditional pets), with secondary exposure to point-of-care emergency settings. Named customers include specialty providers such as MedVet, GCVS Healthcare, and NorthStar VETS, alongside mid-market general practice and exotic clinics.

Moichor distributes directly through its own sales motion and demo-request funnel, and — as of a February 2026 commercial agreement — through a channel partnership with Zomedica Corp. to sell co-branded TRUVIEW digital microscopy systems integrated with Moichor's AI engine and pathology services across the United States. The company has raised approximately $4 million in disclosed seed funding (led by Neotribe Ventures with Y Combinator participation in April 2021) and operates with 11–50 employees. It is privately held with no parent company and no public listing.

Moichor firmographics

Firmographics
Name
Moichor
Legal name
Moichor Inc.
Website
https://moichor.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
Moichor is a San Francisco-based veterinary diagnostics company that sells Pathview, an AI-powered point-of-care hematology and cytology system trained on 2M+ pathology objects across 350+ species, serving companion animal practices, exotic animal hospitals, and emergency veterinary settings with a hybrid hardware, consumables, and reference lab model.
Ownership category
akta.pro rank

Moichor industry classification

Industry
Product category
Veterinary Diagnostics Software
NAICS
Veterinary Services (541940), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAMADAI
Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAMADAA
Reference Laboratory Testing (Clinical Pathology & Chemistry)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAMAMAG
Veterinary Lab/Imaging Integration & LIS/PACS Connectivity
SECONDARYAFAEANAF
Veterinary Diagnostic Laboratories & Pathology

Keywords

  • Veterinary diagnostics
  • AI pathology analysis
  • Hematology cytology systems
  • Point-of-care diagnostics
  • Veterinary reference lab

Where Moichor is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Moichor business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Pathview System Sales: Sale of AI-powered Pathview image-based CBC and cytology devices to veterinary clinics. First commercially available devices began shipping September 2022.
  2. Recurring Consumables Revenue: Each TRUVIEW system placement generates recurring consumables revenue as system placements grow across customer network. Consumables include testing supplies and reagents needed for diagnostic tests.
  3. Pathology Services: Board-certified pathology services integrated with AI engine, providing expert interpretation of diagnostic results for veterinary practices.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Moichor product offering

Product offering

Core offering

Moichor sells an AI-assisted hematology and cytology point-of-care diagnostic system (Pathview) for veterinary clinics, using computer vision trained on over 2 million pathology objects spanning 350+ species to deliver preliminary diagnostic results in 15 minutes. The company also operates a veterinary Reference Lab service providing board-certified pathology expertise for clinics without in-house Pathview systems.

Product overview

Moichor offers AI-powered veterinary diagnostic products centered on its Pathview platform — an AI-assisted hematology and cytology system for point-of-care clinics — complemented by a Reference Lab service that provides remote pathology expertise. Both products leverage computer vision trained on millions of pathology samples to deliver rapid diagnostic results within 15 minutes, supporting CBC and cytology evaluation across more than 350 species including companion animals, birds, reptiles, and exotic animals.

Differentiator

Problem solved

Functional benefit

Brands

  • Pathview: AI-assisted hematology and cytology system for veterinary clinics, providing pathologist-level results assisted by AI with results in as little as 15 minutes.
  • Reference Lab

Products and services

  • Pathview AI-assisted hematology and cytology system designed for point-of-care veterinary clinics. Provides pathologist-level results in as little as 15 minutes, performing CBC and cytology evaluation for any species including companion animals, birds, reptiles, and exotic animals.
  • Reference Lab Veterinary pathology services providing access to board-certified pathology expertise for clinics that do not have in-house Pathview systems, offering comprehensive diagnostic support for veterinary practices nationwide.

Quantifiable outcome

  • 35%+ average cost savings for veterinary clinics
  • +3 more outcomes

Companies that use Moichor

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Moichor technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Moichor partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ZomedicacoreChannel Partner/ Reseller/ Distributor · 25 February 2026Commercial distribution agreement under which Zomedica supplies its TRUVIEW digital microscopy systems and associated testing supplies for Moichor's sale to point-of-care veterinary customers nationwide. The co-branded systems integrate Moichor's proprietary AI engine and board-certified pathology services, expanding the TRUVIEW platform's reach into companion animal practices and exotic animal hospitals. Each system placement is expected to generate recurring consumables revenue.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Moichor competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Moichor social profiles

Digital presence

Moichor financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Moichor leadership team

Management profile

Number of profiles

Profiles6 records

Moichor funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Moichor M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Moichor

What does Moichor do?

Moichor sells an AI-assisted hematology and cytology point-of-care diagnostic system (Pathview) for veterinary clinics, using computer vision trained on over 2 million pathology objects spanning 350+ species to deliver preliminary diagnostic results in 15 minutes. The company also operates a veterinary Reference Lab service providing board-certified pathology expertise for clinics without in-house Pathview systems.

Is Moichor a public or private company?

Moichor is a private company. It is classified as venture growth investor backed and is currently operating.

When was Moichor founded?

Moichor was founded in 2017. It employs 1 to 10 people.

Where is Moichor based?

Moichor is headquartered in San Francisco, United States, in the North America region.

How does Moichor make money?

Three revenue lines are on record. Pathview System Sales are the primary driver. The others are recurring Consumables Revenue and pathology Services.

Does Moichor have an API?

No public API is recorded for Moichor.

What industry is Moichor in?

Moichor's product category is Veterinary Diagnostics Software. Its primary akta.pro industry code is HLAMADAI, Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers), with a secondary code of HLAMADAA, Reference Laboratory Testing (Clinical Pathology & Chemistry). Its NAICS code is 541940 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DVM 360Exclusive: Moichor opens preorders for image-based CBC point-of-care deviceMoichor, an AI-powered animal diagnostic company, announced it is opening preorders for its image-based point-of-care complete blood count (CBC) device, which the company states is the first of its kind in the veterinary space. The device uses computer vision to sort, share, and analyze pathology objects, enabling STAT pathology review within 2 hours; the company has trained its algorithm on over 2 million pathology objects spanning more than 350 species. The first commercially available devices are expected to begin shipping in September 2022.Stock TitanZomedica inks Moichor deal for TRUVIEW distributionZomedica announced a distribution agreement with Moichor to expand the reach of its TRUVIEW digital microscopy platform in the United States, integrating Moichor's AI engine and pathology services. The partnership aims to accelerate system placements, support recurring revenue, and improve veterinary diagnostic workflows, spanning traditional and exotic animal practices.PharmiWeb.comZomedica Expands Distribution of TRUVIEW(R) Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary PathologyZomedica Corp. announced a commercial distribution agreement with Moichor to expand sales of its TRUVIEW digital microscopy platform across the United States. Under the partnership, Moichor will sell co-branded TRUVIEW systems integrated with its proprietary AI engine and board-certified pathology services to point-of-care veterinary customers nationwide, including companion animal and exotic animal practices. Each system placement is expected to generate recurring consumables revenue for Zomedica, strengthening its long-term growth trajectory and recurring revenue model.BioSpaceZomedica Expands Distribution of TRUVIEW(R) Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary PathologyZomedica Corp. announced a commercial distribution agreement with Moichor, a veterinary pathology services provider, under which Zomedica will supply its TRUVIEW digital microscopy systems and associated testing supplies for Moichor's sale to point-of-care veterinary customers nationwide. The co-branded systems will integrate with Moichor's proprietary AI engine and board-certified pathology services, expanding the TRUVIEW platform's reach into both companion animal practices and exotic animal hospitals. The partnership is expected to drive recurring consumables revenue as system placements grow across Moichor's customer network.American City Business JournalsSan Francisco startup Moichor uses AI to improve veterinary diagnosticsMoichor, a San Francisco startup, uses AI to process veterinary blood tests for cats, dogs, and exotic pets. It raised $6.2 million, bringing total funding to $11.2 million, and serves 49 states. The company plans to open a third lab in Louisville, Kentucky, by early 2024.FinSMEsMoichor Raises $4M in Seed FundingMoichor, a Berkeley-based AI animal diagnostics company, raised $4M in seed funding led by Neotribe Ventures. The company will use the funds to expand automated pathology services and develop a point-of-care device. It previously completed the 2021 Winter Y Combinator program.VC News DailyMoichor Raises $4M Seed RoundMoichor, an AI-powered animal diagnostics company based in Berkeley, California, has raised $4 million in seed capital. Neotribe Ventures, a Menlo Park-based venture firm, led the investment with participation from existing investors, following Moichor's completion of the 2021 Winter Y Combinator program.PR NewswireMoichor raises $4m to disrupt animal blood testingMoichor, an AI-powered animal diagnostics company headquartered in Berkeley, California, announced it raised $4 million in seed capital after completing the 2021 Winter Y Combinator program, with Neotribe Ventures leading the investment. The funding will support expansion of automated pathology services and development of a point-of-care diagnostic device for birds and reptiles, where the company's deep learning models achieve ten times less variability and twice the processing speed compared to current manual complete blood count techniques. The company, founded at Penn State University, aims to improve clinical outcomes for pets by providing faster and more accurate diagnostics directly in veterinary clinics.NewsweekHow a Steve Jobs Quote Inspired a Penn State Student to Want to Change the WorldSherveen Karbasiafshar, a Penn State senior, co-founded Moichor, a smartphone app with test strips for complete blood counts, after being inspired by a Steve Jobs quote. The startup has won $45,000 in non-dilutable funds and continues to grow.